Welcome Event & Info Session
Come to our Welcome Event to meet us! There will be 2 impactful speakers from the biotech field, information on how to get involved in Student Biolab, a special announcement about ‘BioIncubate’ and information about the IGEM & IDEC Teams.
DATE: April 3, 2023
TIME: 18:00 - 20:00
LOCATION: ETH Student Project House - Zentrum; Clausiusstrasse 16, 8006 Zürich
WHO: Students in any level & background
RSVP Below for the Event!
Get Involved with Student Biolab
BioIncubate: Find out how to help plan our incubator this year.
Directed Evolution & IDEC: Hear from the Directed Evolution Project Team & how you can apply to join them at the IDEC international directed evolution conference.
IGEM: Learn from the current IGEM team leaders & how you can get involved.
Speakers in Biotech
Dr. Alexander Schueller | Co-Founder & CEO at Cellvie Inc.
Topic of the talk: Translating medicinal science from bench to bed – how to get started and keep going
Background: Born and raised in Germany, Alex studied business at the Maastricht University, before joining the Boston Consulting Group. In his subsequent pursuit of a PhD he came across a surgical glue technology, upon which he co-founded Adhesys Medical. After building and successfully exiting this first venture, he founded cellvie with a group of researchers from Harvard in 2018 – a biotech-start-up developing a next generation cellular therapy, leveraging mitochondria, the powerhouses of the cell.
Dr. Martin Held | ETH Zürich, D-BSSE
Topic of Talk: Startups that have emerged from the Bioprocess Laboratory of the ETH
Background: Martin Held graduated as a technical biologist at the University of Stuttgart in 1994 and received his PhD for the development of a scaled biocatalytic process for manufacturing of fine chemicals employing and hydroxylating whole cell biocatalysts from the Institute of Biotechnology of the Swiss Federal Institute of Technology (ETH) in 2000. He then chaired a Biotech startup company in Switzerland active in custom manufacturing of biocatalysts and high-value added compounds for pharma applications. In 2003 he went back to ETH and is now group leader of the Technology Development and Discovery Group at the Bioprocess Laboratory of the ETH (group of Professor Sven Panke).